Perspective of the U.S. Food and Drug Administration on concomitant administration of Zostavax and Pneumovax
- PMID: 21864628
- DOI: 10.1016/j.vaccine.2011.08.046
Perspective of the U.S. Food and Drug Administration on concomitant administration of Zostavax and Pneumovax
Comment on
-
Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection.Vaccine. 2011 May 9;29(20):3625-7. doi: 10.1016/j.vaccine.2011.04.019. Vaccine. 2011. PMID: 21524565 Free PMC article. No abstract available.